NASDAQ:BIIB - Biogen Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$335.27 +3.24 (+0.98 %)
(As of 01/17/2019 11:42 AM ET)
Previous Close$332.03
Today's Range$330.07 - $335.27
52-Week Range$249.17 - $388.67
Volume12,028 shs
Average Volume1.28 million shs
Market Capitalization$68.01 billion
P/E Ratio15.35
Dividend YieldN/A

Analyst Ratings

Biogen (NASDAQ:BIIB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
29 Wall Street analysts have issued ratings and price targets for Biogen in the last 12 months. Their average twelve-month price target is $381.8574, suggesting that the stock has a possible upside of 13.90%. The high price target for BIIB is $470.00 and the low price target for BIIB is $262.15. There are currently 7 hold ratings and 22 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.762.752.712.69
Ratings Breakdown: 0 Sell Rating(s)
7 Hold Rating(s)
22 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
21 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
20 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
20 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $381.8574$382.2750$382.8860$361.3019
Price Target Upside: 13.90% upside31.45% upside15.97% upside3.68% upside

Biogen (NASDAQ:BIIB) Consensus Price Target History

Price Target History for Biogen (NASDAQ:BIIB)

Biogen (NASDAQ:BIIB) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/10/2019JPMorgan Chase & Co.Reiterated RatingBuyLowView Rating Details
12/26/2018BTIG ResearchInitiated CoverageBuyHighView Rating Details
12/19/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$394.00 ➝ $401.00LowView Rating Details
12/18/2018OppenheimerLower Price TargetOutperform$380.00 ➝ $372.00HighView Rating Details
12/12/2018Cantor FitzgeraldReiterated RatingBuy$400.00LowView Rating Details
11/26/2018Royal Bank of CanadaLower Price TargetSector Perform$338.00LowView Rating Details
10/24/2018Leerink SwannSet Price TargetHold$328.00 ➝ $340.00HighView Rating Details
10/23/2018Raymond JamesSet Price TargetBuy$400.00MediumView Rating Details
10/23/2018MizuhoSet Price TargetBuy$427.00LowView Rating Details
10/19/2018Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$373.00 ➝ $341.00HighView Rating Details
10/8/2018CitigroupLower Price TargetBuy ➝ Buy$483.00 ➝ $470.00LowView Rating Details
8/7/2018Stifel NicolausInitiated CoverageBuy$394.00HighView Rating Details
7/26/2018UBS GroupBoost Price TargetBuy ➝ Buy$354.00 ➝ $395.00MediumView Rating Details
7/25/2018BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$295.00 ➝ $320.00HighView Rating Details
7/25/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$323.00 ➝ $348.00HighView Rating Details
7/25/2018SunTrust BanksBoost Price TargetBuy$321.00 ➝ $392.00HighView Rating Details
7/24/2018GuggenheimReiterated RatingBuy$410.00HighView Rating Details
7/24/2018CowenReiterated RatingBuy$408.00HighView Rating Details
7/23/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$335.00 ➝ $396.00LowView Rating Details
7/11/2018Piper Jaffray CompaniesBoost Price TargetOverweight$365.00LowView Rating Details
7/9/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Hold$400.00MediumView Rating Details
7/9/2018HC WainwrightReiterated RatingBuyMediumView Rating Details
7/6/2018NomuraReiterated RatingBuy$420.00HighView Rating Details
4/25/2018Goldman Sachs GroupDowngradeConviction-Buy ➝ Buy$388.00 ➝ $262.15HighView Rating Details
4/24/2018Credit Suisse GroupSet Price TargetBuy$384.00HighView Rating Details
3/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$403.00 ➝ $393.00LowView Rating Details
2/16/2018ArgusDowngradeBuy ➝ HoldMediumView Rating Details
2/15/2018William BlairReiterated RatingBuyLowView Rating Details
1/26/2018Deutsche BankReiterated RatingBuy$373.00LowView Rating Details
10/18/2017Bank of AmericaBoost Price TargetBuy$358.00 ➝ $365.00N/AView Rating Details
3/1/2017InstinetInitiated CoverageBuy ➝ Buy$223.03 ➝ $345.00N/AView Rating Details
(Data available from 1/17/2017 forward)
This page was last updated on 1/17/2019 by Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel